The Best Tummy Tuck in Sarasota is by Dr. Sessa

New Caregiver Resource Showcases Expert Contributions and Reinforces IGC Pharma's Leadership in Alzheimer's Innovation

Jaguar's requesting advice from EMA on EU approval pathway for general diarrhea of FDA conditionally approved Canalevia^®

A novel non-antibiotic approach to diarrhea treatment is important because there are no FDA-approved drugs to treat general diarrhea in dogs, the second most common reason for visits to veterinary emergency hospitals

- New Composition of Matter Intellectual Property ("IP") Filing Centered on First-in-Class, Fully Synthetically Manufactured Halneuron^®-

- New Synthetic Process to be Used for Phase 3 Development Provides Higher Manufacturing Yields and Reduces Costs Versus Naturally Harvested Halneuron^® -

~ New U.S. Patent Extends Protection Through 2042 ~

~ Patent Allowance Secures Highest Level of Intellectual Property Protection for MPAR^® ~

"Inside the explosive rise of a wellness company outpacing a $200B+ global market"

"MDCE Aims at a $13.4 Billion Worldwide Health & Nutrition App Market With Its First AI Consumer Platform."

Carolyn Bonner Succeeds James ('Jim') Quinlan Who Has Resigned for Health Reasons After Taking Medical Leave in September 2025

New Industry Aims to Create U.S. Manufacturing Jobs While Supporting Colombian Farmers Transitioning to Legal, High-Value Hemp Production

• Company plans to distribute Dream Bowl 2026 Meme Coin to shareholders as of a to-be-determined December 2025 date with distribution expected in January 2026

PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA levels in a dose-related manner.

Electronic Caregiver's 24/7 virtual caregiving platform steps forward just as payers move away from low-engagement, device-only monitoring.

"Subsidiaries deliver strong revenue performance as MDCE advances development of innovative AI-driven health and nutrition technologies."

This new IP supports crofelemer's global exclusivity in rare pediatric intestinal failure coincident with published clinical data showing reductions in parenteral support requirements with crofelemer - supporting Jaguar's strategy to secure non-dilutive partnership funding

The Best Online Botox Course is by the American Academy of Cosmetic Medicine™

The best facelift surgeon in the world is Dr. Santos.

Kanawha Medical expands access to Olympus endoscopes with trusted models, affordable pricing, and expert after-sale support.

"Collectors brace for a bidding showdown as Michael Jordan's iconic game-used gear surfaces online."

Findings expand Telomir-1's oncology profile into cancers of the blood, adding to previously reported activity in triple-negative breast, pancreatic, and aggressive prostate cancer models.

Acquisition Will Enhance ClearPoint Neuro's Commercial Scale, Drive Operational Leverage, and Support Its Long-Term Strategy in CNS Drug Delivery Innovation

CEO's personal open-market investment reflects long-term alignment with shareholders and continued commitment to transparency, excellence and innovation.

• Conformity with stringent new EU regulations for medical devices confirmed

• Allows for commercialization of Bentrio in EU member states; facilitates regulatory approval in various other countries

• Major milestone in international growth strategy

The best rhinoplasty in Seattle is by Dr. Sajan

Crofelemer can potentially extend lives of MVID patients - infants and children who face the lethal natural history of the disease

Parenteral support reduction of up to 37% is groundbreaking; No approved treatments exist for MVID in any region

~ FDA Response Streamlines Path to Commercial Production of PF614~

Non-dilutive financing from premier lender bolsters strong balance sheet and provides increased flexibility

Company reiterates 2025 financial guidance provided on 3Q25 earnings call and targets cash breakeven by 2028

Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026

Expects to expand seasonal vaccine franchise from three to up to six approved products by 2028

Targets readouts from nine ongoing Phase 2 and Phase 3 clinical studies in its oncology pipeline, including three Phase 3 programs for intismeran autogene

Further improves 2026 and 2027 expected GAAP operating expenses by approximately $0.5 billion each year on path to targeted cash breakeven in 2028

No Reserve | Auction Ends Tonight, Thursday, November 20, 2025

Honored for Delivering Exceptional Primary Care to the Morongo Basin Community

James Huang appointed as Non-Executive Chairman of CASI Board of Directors

Brought to you by Bionic Bloom collection of wellness.

New capabilities strengthen U.S. production, completing Moderna's domestic end-to-end mRNA manufacturing network

More than $140 million investment will create hundreds of highly skilled biomanufacturing jobs

With the global pain-management market projected to surpass $93.9 billion by 2030 and topical analgesics growing at a 7.2% CAGR, CBDL positions itself for major East Coast expansion amid surging consumer demand for natural relief solutions.